|
Mary Lynne Hedley, Ph.D. is Executive Vice President and Chief Scientific Officer. In this position, Dr. Hedley is responsible for the Company’s research, development, pharmacovigilence, and program management activities. Dr. Hedley joined MGI PHARMA Biologics in September 2004 upon the acquisition of ZYCOS, Inc., and most recently was Senior Vice President and Chief Scientific Officer at MGI PHARMA. She was a co-founder of ZYCOS where she served as President and Chief Executive Officer. During her post-doctoral studies at Harvard University, and in conjunction with other scientists, Dr. Hedley co-invented the core technology underlying the MGI PHARMA Biologics platform. Dr. Hedley received her B.S. degree in microbiology from Purdue University and Ph.D. in molecular immunology from Southwestern Medical Center. | 